Literature DB >> 10986536

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data.

M Bonetti1, R D Gelber.   

Abstract

We introduce the subpopulation treatment effect pattern plot (STEPP) method, designed to facilitate the interpretation of estimates of treatment effect derived from different but potentially overlapping subsets of clinical trial data. In particular, we consider sequences of subpopulations defined with respect to a covariate, and obtain confidence bands for the collection of treatment effects (here obtained from the Cox proportional hazards model) associated with the sequences. The method is aimed at determining whether the magnitude of the treatment effect changes as a function of the values of the covariate. We apply STEPP to a breast cancer clinical trial data set to evaluate the treatment effect as a function of the oestrogen receptor content of the primary tumour.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986536     DOI: 10.1002/1097-0258(20001015)19:19<2595::aid-sim562>3.0.co;2-m

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  47 in total

1.  Gene signatures revisited.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2012-01-18       Impact factor: 13.506

2.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

3.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

4.  Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

Authors:  S Aebi; Z Sun; D Braun; K N Price; M Castiglione-Gertsch; M Rabaglio; R D Gelber; D Crivellari; J Lindtner; R Snyder; P Karlsson; E Simoncini; B A Gusterson; G Viale; M M Regan; A S Coates; A Goldhirsch
Journal:  Ann Oncol       Date:  2011-01-31       Impact factor: 32.976

5.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

6.  Using clinical trial data to tailor adjuvant treatments for individual patients.

Authors:  Meredith M Regan; Richard D Gelber
Journal:  Breast       Date:  2007-08-23       Impact factor: 4.380

7.  A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data.

Authors:  Marco Bonetti; David Zahrieh; Bernard F Cole; Richard D Gelber
Journal:  Stat Med       Date:  2009-04-15       Impact factor: 2.373

8.  Evaluating marker-guided treatment selection strategies.

Authors:  Roland A Matsouaka; Junlong Li; Tianxi Cai
Journal:  Biometrics       Date:  2014-04-29       Impact factor: 2.571

9.  Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.

Authors:  Olivia Pagani; Shari Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Stig B Holmberg; Diana Crivellari; John Collins; Jurij Lindtner; Beat Thürlimann; Martin F Fey; Elizabeth Murray; John F Forbes; Alan S Coates; Aron Goldhirsch
Journal:  Breast Cancer Res Treat       Date:  2008-10-25       Impact factor: 4.872

10.  Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.

Authors:  Giuseppe Viale; Anita Giobbie-Hurder; Meredith M Regan; Alan S Coates; Mauro G Mastropasqua; Patrizia Dell'Orto; Eugenio Maiorano; Gaëtan MacGrogan; Stephen G Braye; Christian Ohlschlegel; Patrick Neven; Zsolt Orosz; Wojciech P Olszewski; Fiona Knox; Beat Thürlimann; Karen N Price; Monica Castiglione-Gertsch; Richard D Gelber; Barry A Gusterson; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2008-11-03       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.